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We determined complete genome sequences of lineage 
2 West Nile virus (WNV) strains isolated from patients in 
South Africa who had mild or severe WNV infections. These 
strains had previously been shown to produce either highly 
or less neuroinvasive infection and induced genes similar to 
corresponding highly or less neuroinvasive lineage 1 strains 
in mice. Phylogenetic and amino acid comparison of highly 
and less neuroinvasive lineage 2 strains demonstrated that 
the nonstructural genes, especially the nonstructural pro-
tein 5 gene, were most variable. All South African lineage 
2 strains possessed the envelope-protein glycosylation site 
previously postulated to be associated with virulence. Major 
deletions existed in the 3′ noncoding region of 2 lineage 2 
strains previously shown to be either less or not neuroinva-
sive relative to the highly neuroinvasive strains sequenced 
in this study. 
W
est Nile virus (WNV) is endemic to Africa, Asia, 
Europe, and Australia and was introduced into the 
Western Hemisphere in 1999. In the Northern Hemisphere, 
an apparent increase in human case fatality rates, neuro-
logic infections, and horse and bird deaths due to WNV has 
raised the question whether WNV strains with increased 
pathogenicity have emerged in the Northern Hemisphere, 
or whether the virulence of the virus and the severity of the 
disease are underestimated in South Africa.
Two major phylogenetic lineages of WNV have been 
demonstrated: lineage 1 includes viruses from North Africa, 
Europe, Asia, the Americas, and Australia (Kunjin virus); 
lineage 2 consists exclusively of viruses from southern Af-
rica and Madagascar. The increase in illness and death from 
WNV lineage 1 strains relative to lineage 2 strains led to 
the supposition that lineage 1 strains are highly pathogenic 
while lineage 2 strains endemic to Africa are of low viru-
lence (1,2). However, it was subsequently demonstrated in 
South Africa that lineage 2 strains may also cause severe 
disease (3). Furthermore, experiments using mice demon-
strated marked differences in neuroinvasive phenotype that 
did not correlate with lineage, which suggests that highly 
and less neuroinvasive phenotypes exist in both lineages 
(2,4). Host gene expression studies indicated that similar 
genes are induced by highly neuroinvasive lineage 1 and 
2 strains (4). Therefore, the perceived virulence of WNV 
in recent epidemics probably reﬂ  ects high medical alert-
ness, active surveillance programs, and the emergence and 
reemergence of existing strains of WNV in locations with 
immunologically naive populations (3). Recently, a lineage 
2 strain was isolated from a goshawk ﬂ  edgling that died 
of encephalitis in Hungary, which suggests that lineage 2 
strains may also be spread by migratory birds outside of 
Africa (5).
Lineage 1 viruses that have phenotypes of reduced 
virulence in mice and inefﬁ  cient growth in culture have 
been identiﬁ  ed in Mexico. Mutations leading to loss of 
envelope (E) protein glycosylation together with muta-
tions in the nonstructural (NS) protein genes may be as-
sociated with attenuation of these viruses (6). Comparisons 
between the prototype Uganda strain (B956) and a variant 
of this strain, which was obtained by molecular mutation 
(B956D117B3), showed changes in the E and NS genes, 
which resulted in reduced virulence in mice (7). These at-
tenuations could not, however, be correlated with clinical 
disease in humans because these strain were either isolated 
from birds or modiﬁ  ed in culture.
The NS4B protein may play an important role in viru-
lence phenotype determination (6,8–10), predicted to be 
involved in viral replication and evasion of host innate 
Genetic Determinants of 
Virulence in Pathogenic Lineage 2 
West Nile Virus Strains
Elizabeth M. Botha,* Wanda Markotter,* Mariaan Wolfaardt,* Janusz T. Paweska,† Robert  Swanepoel,† 
Gustavio Palacios,‡ Louis H. Nel,* and Marietjie Venter*  
RESEARCH
222  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 2, February 2008
*University of Pretoria, Pretoria, South Africa; †National Institute 
for Communicable Diseases, Sandringham, South Africa; and 
‡Columbia University, New York, New York, USAGenetic Determinants of WNV Virulence 
immune defenses (8). Substitution of cysteine at position 
102 with serine (Cys102Ser) led to the formation of a tem-
perature-sensitive phenotype at 41°C as well as attenuation 
of the neuroinvasive and neurovirulent phenotypes in mice 
(8). An adaptive mutation (E249G) in the NS4B gene re-
sulted in reduced RNA synthesis in host cells (9). An in 
vitro study compared infectious clones of the NY99 strain, 
which is highly virulent in American crows, with a Kenya 
strain (KEN-3829), which is less virulent for American 
crows. After 72 days at 44°C, reduction in viral RNA pro-
duction by the KEN-3829 strain was 6,500-fold, compared 
with the NY99 strain reduction of 17-fold. This ﬁ  nding 
suggested that efﬁ  cient replication at high temperatures, 
as occurs in American crows, could be an important viru-
lence factor that determines the pathogenic phenotype of 
the NY99 strain (10).
To further investigate the molecular determinants of 
virulence of lineage 2 WNV strains, we sequenced the ge-
nomes of highly and less neuroinvasive lineage 2 strains 
that were isolated from patients in South Africa and that 
had previously been characterized with respect to gene ex-
pression and pathogenicity (4). These complete genome 
sequences of highly neuroinvasive lineage 2 WNV strains 
enable comprehensive comparison with highly and less 
neuroinvasive lineage 1 strains.
Materials and Methods
Virus Strains
South African WNV isolates SPU116/89, SA93/01, 
SA381/00, and H442 were obtained from the Special 
Pathogens Unit, National Institute for Communicable Dis-
eases, South Africa, as freeze-dried mouse brain passages 
2–4. They were replicated by 1 passage in Vero cells for 
this study.
RNA Ampliﬁ  cation
Viral RNA was extracted from cell culture supernatant 
with the QIAamp Viral RNA Mini Kit (QIAGEN, Hilden, 
Germany) according to the manufacturer’s instructions. For 
cDNA synthesis, 10 μL of RNA and 0.4 μg of random hexa-
nucleotides (Roche Diagnostics, Mannheim, Germany) were 
incubated at 65°C for 10 min before cooling on ice. Then 1× 
Expand Reverse Transcriptase buffer, 100 mmol/L dithioth-
reitol, 200 μmol of each deoxynucleotide triphosphate, 20 
U RNase Inhibitor and 50 U Expand Reverse Transcriptase 
(Roche Diagnostics) were added and incubated at 30°C for 
10 min, followed by 1 h at 43°C. For PCR ampliﬁ  cation, 10 
μL of the cDNA reaction was added to the PCR master mix 
consisting of 3.75 U of Expand High Fidelity Polymerase 
and 30 pmol of each speciﬁ  c primer (primer sequences avail-
able on request) and cycled as follows: 94°C for 2 min (94°C 
for 15 s, followed by primer-speciﬁ  c annealing temperature 
for 30 s, 72°C for 2 min) × 35 and 72°C for 7 min. Expand 
Long Template PCR Polymerase (Roche Diagnostics) was 
used for products >2 kb with 300 μmol of each dNTP, 1× 
buffer, and 30 pmol of each speciﬁ  c primer and cycled at 
94°C for 2 min (94°C for 10 s, 50°C for 30 s, 68°C for 3 min) 
× 10; followed by 30 cycles of 94°C for 15 s, 50°C for 30 s, 
68°C for 5 min plus 5 s per cycle, and 72°C for 7 min.
DNA Sequencing
PCR products were puriﬁ  ed with Wizard SV gel and 
PCR clean-up system (Promega, Southampton, UK). DNA 
cycle sequencing was performed with the BigDye Termi-
nator V3.1 kit and analyzed on an ABI PRISM 3100/3130 
genetic analyzer (both from Applied Biosystems, Foster 
City, CA, USA).
Sequence Analysis
Genome editing and assembling were performed by us-
ing Vector NTI 9.1.0 (Invitrogen, Carlsbad, CA, USA); mul-
tiple sequence alignments, with ClustalW (11); and amino 
acid analysis, with GeneDoc for Windows (12). Amino acid 
changes considered to have a potential effect on the second-
ary structure of the proteins included substitution of hydro-
philic for hydrophobic amino acids or vice versa and substi-
tutions of cysteine, glycine, and proline residues (12).
Comparisons are relative to the top sequence 
(SA381/00); numbering refers to the sequence position of 
isolate SA381/00. Neighbor-joining trees were drawn with 
MEGA version 3.1 (13) by using the Kimura-2 distance-
parameter and a bootstrap conﬁ  dence level of a 1,000 rep-
licates. Nucleotide and amino acid p-distances (the number 
of pairwise nucleotide or amino acid differences divided 
by the total number of nucleotides or amino acids in the 
sequenced region) were calculated by using MEGA version 
3.1. Signalase cleavage predicted scores were calculated 
with AnalyzeSignalase 2.03 (14).
Results
Strain Characteristics
Four lineage 2 WNV strains isolated from patients 
in South Africa who had mild or severe WNV infections 
were selected for genome sequencing. Phenotypic pathoge-
nicity data for these strains (H442, SPU116/89, SA93/01, 
SA381/00) in humans and mice are summarized in Table 1. 
Detailed clinical data for all 4 strains have been described 
by Burt et al. (3), and mouse neuroinvasive experiments and 
gene expression data for H442, SPU 116/89, and SA381/00 
have been described by Venter et al. (4). Strain SA93/01 
has been shown to be highly neuroinvasive in a mouse 
model (M. Venter, unpub. data), similar to SPU116/89 
and H442 strains, whereas SA381/00 has been classiﬁ  ed 
as being of low neuroinvasive phenotype in mice. H442 
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and SA381/00 caused fever, rash, myalgia, and arthralgia 
in human patients; SA93/01 caused nonfatal encephalitis in 
2, and SA116/89 caused fatal hepatitis (3).
The 4 South African strains were compared with 
strains that were known to be highly or less neuroinvasive 
in mice or that had been reported to be highly pathogenic 
or attenuated. Lineage 2 strains for which both full genome 
sequences and neuronvirulence data in mice were available 
included isolate B956D117B3 (21) and Madagascar strain 
AnMg798. B956D117B3 is a passaged clone of reduced 
virulence (7) of the prototype strain (B956), which was 
originally associated with fever in a patient and was neu-
rotropic in mice (22); AnMg798 is not neuroinvasive (2). 
Lineage 1 strains included the highly pathogenic and neu-
roinvasive NY385–99 strain (2), the attenuated non-neuro-
invasive strain TM171–03 isolated in Mexico in 2003 (19), 
hamster-passaged attenuated clones of NY-385–99 (clone 
TYP-9376 and clone 9317B) (18), and a non-neuroinvasive 
Kunjin virus strain MRM61C (Table 1).
Phylogenetic Analysis
Phylogenetic analysis conﬁ  rmed that the South Afri-
can strains described here belong within lineage 2 (Figure 
1). SA93/01 and SPU116/89 clustered together; H442 and 
SA381/00 were on separate branches within lineage 2 with 
respect to the full genome sequences or with respect to indi-
vidual E, NS3, and NS5 genes (data not shown). Although 
the Indian strain clustered with lineage 1, p-distance analy-
sis suggested that it was as distant to the lineage 1 strains 
(20% differences) as to the lineage 2 strains (21%–22%) 
relative to <5% differences within lineage 1C and 12% dif-
ferences between 1A and 1B. It was therefore termed lin-
eage 5, as suggested by Bondre et al. (23).
Genome Sequences and Distance Analysis
The complete genome sequences of strains H442, 
SPU116/89, SA381/00, and SA93/01 were deposited in 
GenBank (accession nos. EF429197–200). The termini 
were ampliﬁ  ed with primers designed from other lineage 
2 full genome sequences. If one assumes that the 5′ and 3′ 
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Table 1. Characteristics and origin of West Nile virus strains included in this investigation*  
Strain, year of 
isolation Passage Source Location Syndrome Outcome L Neuro Glyco    Ref GenBank
SPU116/89,
1989
Mouse 3  Human SA Necrotic
hepatitis
Died 2 High NYS† This
study 
EF429197
SA93/01, 2001  Mouse 1  Human SA Fever, rash, 
myalgia, 
encephalitis
Survived 2 High NYS† This
study 
EF429198
SA381/00, 2000  Mouse 1  Human SA Fever, rash, 
myalgia, 
arthralgia 
Survived 2 Mild NYS†  This 
study 
EF429199
H442, 1958  Mouse 2  Human SA Fever, rash, 
myalgia, 
arthralgia 
Survived 2 High NYS† This
study 
EF429200
B956, 1937  Mouse 2  Human Uga Febrile
disease
Survived 2 Mild Deletion
of entire 
motif
(7) AY532665 
B956D117B3,‡
1937
Unknown Human Uga Febrile
disease
Survived 2 Less
than
B956
Deletion
of entire 
motif
(15) M12294
Madagascar-
AnMg798, 1978 
Unknown Parrot§    Mad NA Died 2 None NYP  (16) DQ176636 
NY 385–99, 
1999
Vero 2  Human USA Unknown  Unknown  1 High NYS†  (17) DQ211652 
NY-385–99 
Clone TYP-9376, 
2005
Hamster Hamster USA NA NA 1 None¶ NYS† (18) AY848697 
NY-385–99 
Clone 9317B, 
2005
Hamster Hamster USA NA NA 1 None¶ NYS† (18) DO66423 
TM171–03, 2003  Vero 1  Common
raven
Mex Unknown Died 1 None¶ NYP  (19) AY660002 
MRM61C, 1960  NA Mosquito# Aus NA NA 1 None NYF  (20) D00246
*L, lineage; Neuro, neuroinvasiveness in mice; Glyco, glycosylation of envelope protein; Ref, reference no.; GenBank, GenBank accession no.; SA, South 
Africa; Uga, Uganda; Mad, Madagascar; NA, not applicable; USA, United States; Mex, Mexico; Aus, Australia. 
†Strains that are glycosylated in the envelope protein positions 154–156.  
‡A descendant of B956.  
§Coracopsis vasa.
¶Attenuated laboratory strains. 
#Culex annulirostris.Genetic Determinants of WNV Virulence 
termini are identical in length to other published strains, 
these genomes were 11052 nt (SPU116/89, SA381/00, and 
SA93/01) and 11051 nt (H442) long. South African strains 
had overall nucleotide p-distances of 0.0278 (97.2% simi-
larity) to each other (Table 2), with <1% amino acid differ-
ences over the complete genome despite having been iso-
lated as many as 50 years apart. The highest percentage of 
amino acid differences in the individual proteins of the lin-
eage 2 strains were in the NS proteins, especially the NS5 
protein. Table 3 shows the differences between individual 
proteins of the South African lineage 2 strains.
The 2 strains from North America, New York (NY-
385–99) and Mexico (TM171–03), were similarly con-
served. In contrast, the Madagascar strain, AnMg798, dif-
fered by >3% at the amino acid level from all lineage 2 
strains from South Africa or Uganda B956D117B3, and the 
lineage 1 and 2 strains differed by >6% amino acids from 
each other.
Amino Acid Differences between Highly 
and Less Neuroinvasive Strains
Few amino acid differences were observed between 
the structural proteins of the South African strains (Figure 
2). SA381/00 had only 1 difference in the premembrane 
(prM) protein at position 105 relative to the highly neuro-
invasive strains (Ala105Val) (Figure 2). Two differences, 
(Ala54Gly and Thr70Pro) could result in structural chang-
es in the E protein of H442, which was isolated 50 years 
earlier than strains SPU116/89, SA93/01, and SA381/00. 
The attenuated lineage 2 strain B956D117B3 and the non-
neuroinvasive Madagascar strain AnMg798 contained dif-
ferences in the glycosylation site of the E protein relative 
to the South African strains (residues 154–157 deleted in 
B956D117B3, and Ser156Pro in AnMg798). Either of 
these changes would prevent glycosylation. Further substi-
tutions of hydrophilic amino acids for proline and glycine 
residues with potentially structural implications were found 
in AnMg798 at positions 156, 199, and 230.
The NS3, NS4A/B, and NS5 proteins were the most 
variable viral proteins. In strain SA381/00, the least viru-
lent of the 4 strains, a hydrophobic amino acid in contrast 
to a hydrophilic amino acid (Ser160Ala) and Arg298Gly 
could alter the structure of the SA381/00 NS3 protein. In 
the highly pathogenic strain SPU116/89, a hydrophobic-to-
hydrophilic mutation (Ala79Thr) in NS4B is found relative 
to the other strains. Other amino acid changes with poten-
tial structural implications were for strain B956D117B3 at 
positions 18 and 145 of the NS4A gene and 14 of the NS4B 
gene and for strain AnMg798 at positions 14 and 27 in the 
NS4B gene of (Figure 2).
The NS5 protein was the most variable. Several posi-
tions were identiﬁ  ed where the South African strains asso-
ciated with mild infections (SA381/00 and H442) and the 
2 other lineage 2 strains (AnMg798,B956D117B3) associ-
ated with reduced virulence in mice had the same amino 
acid changes relative to strains that caused severe disease 
(SPU116/89 and SPU93/01). These included hydrophilic 
versus hydrophobic amino acids in position 614 and hydro-
phobic (mild) versus hydrophilic (pathogenic) in positions 
625 and 626 of the NS5 protein. SPU116/89, isolated from 
a patient with necrotic hepatitis, was found to have amino 
acid changes that affect the hydrophobicity of the NS5 pro-
tein relative to all other strains in positions 197, 623, 635, 
641, and 643.
Noncoding Regions
Approximately 98.6% identity existed between the 5′ 
noncoding regions of SA381/00 and the 3 remaining South 
African strains; the other strains were 100% conserved. For 
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Figure 1. Phylogenetic analysis of full genome nucleotide 
sequences of lineage 1 and 2 strains of West Nile virus. The 
tree was constructed by using MEGA version 3.1 (13) with the 
neighbor-joining method and Kimura 2-parameter distance matrix. 
A bootstrap conﬁ  dence level of 1,000 replicates was used. South 
African strains sequenced in this study are indicated by a black 
circle. GenBank accession nos. are as follows: NY-385–99 clone 
9317B (DO66423), NY-385–99 clone TVP-9376 (AY848697), NY 
385–99 (DQ211652), NY-382–99 FLAM (AF196835), IS-98 STD 
(AF481864), Mexico-TM171–03 (AY660002), TX 2002 2, (DQ 
164205), goose-Hungary/03 (DQ 118127), Eg 101 (AF 260968), 
RO97–50 (AF260969), Morocco 96–111 (AY701412), Italy 1998-Eq 
(AF 404757), KN3829 (AY262283), LEIV-Vlg00–27924 (AY278442), 
PaH001 (AY268133), Ast02–2-696 (DQ411035), MRM61C (KUN) 
(D00246), IND804994H (DQ 256376), AnMg798 (DQ 176636), 
SA381/00 (EF429199), H442 (EF429200), goshawk-Hungary/04 
(DQ 116961), SPU116/89 (EF429197), SA93/01 (EF429198), 
B956D117B3 (M12294), B956 (AY532665), ArD76104 (DQ 
318019), Rabensburg isolate 97–103 (AY765264), LEIV-Krnd88–
190 (AY277251), and M18370 JEV (M18370).RESEARCH
the 3′ noncoding regions, the overall identity was 98.5% 
(99% between SPU381/00 and H442 and 98% between 
SPU116/89 and SA381/00). Noteworthy nucleotide differ-
ences in the 3′ noncoding regions were a 2-nt deletion at nt 
10439 and nt 10440 in strain H442 and a 76-bp deletion in 
the 3′ noncoding region from nt 10404 through nt 10479 in 
the attenuated strain B956D117B3, which was not present 
in the prototype strain (B956) or in any of the South Af-
rican strains. Strain AnMg798 had deletions overlapping 
those of strain B956D117B3 at position 10411 to 10487 
and from 10501 to 10512 and 10951 (Figure 2, panel B). 
The sequence of the AnMg798 strain is incomplete in Gen-
Bank and ended at position 10866 (16).
Envelope-Protein Glycosylation Motif
The E protein glycosylation motif previously identiﬁ  ed 
in lineage 1 at positions 154–156 (NYS) (6) was present in 
all 4 South African strains. However, as a result of a proline 
substitution at position 156, the site was not predicted to be 
glycosylated in strain AnMg798. The glycosylation motif 
is deleted completely in strains B956 and B956D117B3 
(Table 1).
Cleavage Sites
Signalase prediction algorithms were used to analyze 
the signal peptidase cleavage sites (14); no differences were 
found in cleavage efﬁ  ciency between the highly and less 
pathogenic strains (Table 4). The only meaningful differ-
ence was observed in the capsid (C)–PrM cleavage region, 
as indicated by the Student t test probability calculated in 
Table 4, where the lineage 2 strains were predicted to be 
cleaved more efﬁ  ciently than lineage 1 stains. Only slight 
differences were apparent in the PrM-E site; no differences 
were apparent in any other cleavage regions between lin-
eage 1 and 2 strains.
Discussion
Phylogenetic and p-distance analyses suggested that 
relationships between WNV strains were inﬂ  uenced  by 
geographic rather than temporal factors (Figure 1, Tables 
2, 3). Four South African strains isolated over 50 years dif-
fered from each other by an average of only 3% of nucleo-
tides but from the AnMg798 (Madagascar) strain by 21%.
The WNV genome consists of a 5′ noncoding region, 
a single open reading frame coding for 3 viral structural 
proteins (C, M, and E) and 7 NS proteins, and a 3′ non-
coding region. The E and membrane (M) proteins are as-
sociated with host range, tissue tropism, replication, as-
sembly, and the stimulation of the B- and T-cell immune 
responses; replication functions are associated with the NS 
proteins, which may also modulate responses to viral infec-
tion (6). The E protein is the viral hemagglutinin that me-
diates virus–host cell binding and elicits most of the virus 
neutralizing antibodies and serotype speciﬁ  city of the virus 
(1,24,25).
In this study, differences between highly and less neu-
roinvasive lineage 2 stains were identiﬁ  ed in the noncoding 
regions, which may potentially affect enzyme binding sites 
and replication efﬁ  ciency (Figure 2, panel B). It has been 
postulated that the 3′ stem loop structure may function as 
a translation suppressor (26) and that nucleotide sequence 
variation in the 3′ noncoding region of different dengue 
strains may have evolved as a function of transmission or 
replication ability in different mosquito and nonhuman pri-
mate/human host cycles (27). A 76-bp deletion in the 3′ 
noncoding region is present in strains B956D117B3 and 
AnMg798 relative to the South African strains. This dele-
tion is not present in the original neurotropic mouse brain 
isolate of the B956 Uganda strain, which has recently been 
resequenced (7). Strain B956D117B3, a descendent of the 
original B952 isolate, has been shown to be less virulent 
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Table 2. Percentage of amino acid and nucleotide differences when comparing the entire genome of selected West Nile virus strains*
Strain
SA381/
00 H442
SPU116
/89
SA93/0
1
B956D1
17B3 B956
ANMg7
98
NY-
385–99
NY-385–
99 Clone 
TYP-9376 
NY-385–
99 Clone 
9317B
TM171–
03
MRM6
1C
SA381/00 2.4 3.6 3.7 3.1 2.9 15.8 20.6 20.6 20.6 20.6 20.5
H442 0.7 2.7 3.0 1.8 1.6 15.6 20.5 20.6 20.6 20.5 20.6
SPU116/89 0.9 0.7 1.3 2.0 1.9 16.0 20.8 20.9 20.9 20.8 20.7
SA93/01 0.8 0.7 0.6 2.3 2.2 15.7 20.8 20.9 20.9 20.8 20.6
B956D117B3 1.0 0.8 1.0 0.9 0.3 15.7 20.7 20.7 20.7 20.7 20.6
B956 0.7 0.6 0.7 0.7 0.7 15.8 20.7 20.7 20.7 20.7 20.6
AnMg798 3.4 3.3 3.5 3.4 3.5 3.4 21.5 21.5 21.5 21.4 21.2
NY-385–99 6.0 5.9 6.1 6.1 6.1 6 6.6 0.1 0.1 0.4 11.7
NY-385–99  
Clone TYP-
9376
6.1 6.0 6.2 6.2 6.2 6.1 6.7 0.1 0 0.5 11.8
NY-385–99  
Clone 9317B 
6.1 6.0 6.2 6.2 6.2 6.1 6.7 0.1 0.0 0.5 11.8
TM171–03 6.0 5.9 6.1 6.1 6.1 6 6.7 0.1 0.2 0.2 11.8
MRM61C 6.5 6.5 6.7 6.6 6.6 6.5 7.1 2.4 2.4 2.4 2.4
*The lower left matrix corresponds to amino acid sequences, and the upper right matrix corresponds to nucleotide sequences. Genetic Determinants of WNV Virulence 
than the original B956 strain. The absence of this deletion 
in all of the neuroinvasive lineage 2 strains isolated from 
clinical cases warrants further investigation of the role of 
the region in the pathogenicicty of WNV.
The genetic stability observed in the surface E and M 
proteins of lineage 2 strains suggests an absence of im-
mune-driven selection. Only the H442 strain, isolated 50 
years before the other strains, had 2 substitutions in the E 
gene with potential structural implications (Figure 2). The 
absence of a putative E protein glycosylation site at posi-
tions 154–156 of the E protein (NYS) has previously been 
associated with reduced virulence in mice (19). This glyco-
sylation motif was present in all the South African strains, 
including the less neuroinvasive strain SA381/00. How-
ever, the prototype lineage 2 strain B956D117B3 and the 
non-neuroinvasive lineage 1 and 2 strains MRM61C and 
AnMg798 were not glycosylated. This ﬁ  nding further em-
phasizes that glycosylation of the E protein is not the only 
determining factor for virulence.
Most substitutions were found in the NS proteins, in 
particular NS3, NS4A/B, and NS5. The NS3 protein is part 
of the protease complex, which is important for cleavage of 
the polyprotein and may affect virulence; it has been sug-
gested that less efﬁ  cient cleavage results in delayed virus 
assembly and release, enabling the host immune system to 
clear infection (28). The NS3 protein of the less neuroinva-
sive strain, SA381/00, manifested hydrophobic and hydro-
philic changes, which could lead to structural changes that 
affect function and, by implication, virulence. The highly 
neuroinvasive strain SPU116/89 had mutations that may al-
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Table 3. Percentage amino acid and nucleotide differences when 
comparing individual proteins of selected West Nile virus strains* 
Strain SA381/00 H442 SPU116/89 SA93/01
Capsid
SA381/00
H442 0
SPU116/89 0 0
SA93/01 0 0 0
Envelope
SA381/00
H442 0.8
SPU116/89 0.2 0.6
SA93/01 0.2 0.6 0
NS2A/B
SA381/00
H442 0.6
SPU116/89 0.3 0.8
SA93/01 0.3 0.8 0
NS4A/B
SA381/00
H442 0.2
SPU116/89 0.2 0.5
SA93/01 0 0.2 0.2
prM
SA381/00
H442 0.6
SPU116/89 0.6 0
SA93/01 0.6 0 0
NS1
SA381/00
H442 0.9
SPU116/89 0.9 0
SA93/01 1.1 0.3 0.3
NS3
SA381/00
H442 0.8
SPU116/89 0.6 0.5
SA93/01 0.6 0.5 0
NS5
SA381/00
H442 0.8
SPU116/89 2.1 1.5
SA93/01 1.9 1.3 2.0
*prM, premembrane; NS, nonstructural. 
Figure 2. A) Amino acid differences between South African lineage 
2 strains of West Nile virus (WNV) strains sequenced in the 
present study and previously published lineage 2 strains. Strain 
SA381/00 is less neuroinvasive than the highly neuroinvasive 
strains SA93/01, H442, and SPU116/89. Light gray, hydrophobic 
amino acids; dark gray, hydrophilic amino acids; black, structural-
determining amino acids; white blocks, deletion of the glycosylation 
site in the envelope protein of the B956D117B3 strain. Numbering 
is according to the SA381/00 genome position for speciﬁ  c genes. 
Cap, capsid; prM, premembrane; NS, nonstructural. B) Nucleotide 
differences in the noncoding 5′ and 3′ regions of lineage 2 strains. 
Numbering is according to WNV strain SA381/00. Black, deletions; 
gray, nucleotide differences. The length of each genome is given 
in the last column. (Strain AnMg798 is incomplete in the GenBank 
database and may thus be longer than indicated.)RESEARCH
ter the hydrophobicity of the NS4B protein (Ala79Thr) rel-
ative to the other strains and may have potential structural 
and functional implications for the viral replicase complex 
of which NS4B is a component (25).
Most amino acid differences occurred in the NS5 pro-
tein, which is associated with cytoplasmic RNA replication 
because it contains an RNA-dependent RNA polymerase, 
S-adenosylmethionine methyltransferase, and importin β–
binding motifs (28). Deletions in the NS5 protein abolish 
replication (29), which suggests that amino acid substitu-
tions may effect replication efﬁ  ciency and, hence, viru-
lence. Temperature-sensitive strains with reduced virulence 
for mice, isolated in Texas, also contained mutations in the 
NS proteins (30). In addition, organ tropism of strains has 
been associated with mutations in the NS5, NS2, and E pro-
teins (18). The 2 lineage 2 strains that caused mild disease 
in patients (H442 and SA381/00) had several substitutions 
of hydrophobic to hydrophilic amino acids relative to the 
other 2 strains in the NS5 protein. SPU 116/89, isolated 
from a patient with necrotic hepatitis, had several amino 
acid changes that may affect its hydrophobicity and result 
in structural and functional changes that have implications 
for altered replication efﬁ  ciency, tissue tropism, and patho-
genicity.
Flavivirus polyproteins are cleaved either by a host 
signal peptidase or a viral-encoded serine protease consist-
ing of the NS3 protease and the NS2B cofactor (NS2B-
NS3) (29). Proteolytic processing of the C-prM and NS4A/
B proteins occurs efﬁ  ciently only after upstream cleavage 
of the signal sequence by cytoplasmic viral protease. Ef-
ﬁ  ciency of signal peptidase cleavage at the NH2 termini of 
prM and NS4 proteins is increased by coexpression of the 
viral NS2B-NS3 protease and the structural polyprotein 
region (31). Mutagenesis analysis of the signal sequence 
of yellow fever virus prM protein indicated that mutations 
that enhance cleavage by the signal peptidase almost to-
tally suppress production of infectious virions (31). Signal 
peptidase cleavage of prM protein results in the produc-
tion of membrane-anchored forms of the C protein, which 
may be deleterious for replication if it functions poorly as a 
substrate for viral protease. The signal peptidase-mediated 
cleavage at the NH2 terminus of prM protein does not oc-
cur efﬁ  ciently, whereas cleavage at the NH2 terminus of the 
E protein does. Inadequate prM protein production in turn 
affects production and lowers the secretion of prM-E het-
erodimers. When these constructs are used in vaccination 
studies, a lack of immunogenicity is noted (32).
In the present study, all highly and less pathogenic lin-
eage 2 strains as well as lineage 1 strains were predicted 
to be cleaved with the same efﬁ  ciency. At the C-prM site, 
lineage 2 strains are cleaved slightly more efﬁ  ciently than 
lineage 1 strains; at prM-E, the reverse is true. How these 
differences in cleavage efﬁ  ciency affect pathogenicity is 
unclear and may warrant further investigation.
The high number of cases of neurologic infections in 
recent epidemics in the United States may be attributed 
to the rapid distribution of a single highly neuroinvasive 
strain in a highly susceptible population. The comparative-
ly low number of WNV fever or neurologic cases reported 
in South Africa, despite the wide distribution of the virus 
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Table 4. Summary of cleavage scores predicted for cleavage junctions of proteins of West Nile virus strains* 
SA381/
00 H442
SPU116/
89 SA93/01
B956D1
17B3
AnMg79
8
NY-385–
99
NY-385–
99 clone 
TYP-
9376
NY-385–
99 clone 
9317B
TM171
–03 MRM61C
p
value†
Between capsid and premembrane proteins 
G +3.69 +3.69 +3.69 +3.69 +3.69 +4.00  0.49  0.49  0.49  0.49  1.85 0.00005
A‡ +9.37 +9.37 +9.37 +9.37 +9.37 +8.01 +5.93 +5.93 +5.93 +5.93 +7.37 0.00004
V  9.14  9.14  9.14  9.14  9.14  7.8  9.52  9.52  9.52  9.52  10.32 0.02235
Between premembrane and envelope proteins 
Y  10.15  10.15  10.15  10.15  10.15  9.12  9.12  9.12  9.12  9.12  9.45 0.00433
S‡ +11.27 +11.27 +11.27 +11.27 +11.27 +12.42 +12.42 +12.42 +12.42 +12.42 +11.50 0.01728
F  5.37  5.37  5.37  5.37  5.37  4.78  4.78  4.78  4.78  4.78  5.27 0.01977
Between envelope protein and nonstructural protein 1 
H  9.01  9.01  9.01  9.01  9.01  9.71  9.01  9.01  9.01  9.01  9.01 0.36322
A‡ +4.26 +4.26 +4.26 +4.26 +4.26 +4.04 +4.26 +4.26 +4.26 +4.26 +4.26 0.36322
D  11.05  11.05  11.05  11.05  11.05  11.15  11.05  11.05  11.05  11.05  11.05 0.36322
Between nonstructural proteins 4B and 5 
R  16.05  16.05  16.05  16.05  16.05  16.05  16.05  16.05  16.05  15.83  16.05 0.37390
G‡  13.19  13.19  13.19  13.19  13.19  13.19  13.19  13.19  13.19  13.08  13.19 0.37390
G  19.54  19.54  19.54  19.54  19.54  19.54  19.54  19.54  19.54  19.66  19.54 0.37390
*Signal cleavage predicted scores were calculated with AnalyzeSignalase 2.03 (14). The table indicates only the last amino acid of the first protein and 
the first 2 amino acids of the following protein.  
†Two-tailed Student t test results, indicating the probability of significance of observed differences between lineage 2 and lineage 1 strains. 
‡Exact cleavage site.  Genetic Determinants of WNV Virulence 
and the presence of neuroinvasive strains, may reﬂ  ect inad-
equate surveillance and a lack of medical awareness of the 
disease potential of arboviruses. Moreover, the importance 
of WNV in South Africa may be overshadowed by the 
presence and effect of other diseases such as HIV/AIDS. 
Nevertheless, the epidemic potential and effect that WNV 
may have on a large population of immunocompromised 
HIV-infected persons necessitates improved surveillance 
of arbovirus infections of persons in southern Africa. 
In conclusion, these full genome sequences provide 
insight into the molecular factors that may differentiate 
pathogenic from mild lineage 2 WNV strains. Mutations 
in the NS proteins encoding viral replication and protein 
cleavage mechanisms are the most likely determinants of 
differences in pathogenicity. 
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